These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 30697640)
1. Down-Regulation of SIRT1 Expression by mir-23b Contributes to Lipid Accumulation in HepG2 Cells. Borji M; Nourbakhsh M; Shafiee SM; Owji AA; Abdolvahabi Z; Hesari Z; Ilbeigi D; Seiri P; Yousefi Z Biochem Genet; 2019 Aug; 57(4):507-521. PubMed ID: 30697640 [TBL] [Abstract][Full Text] [Related]
2. miR-122 promotes hepatic lipogenesis via inhibiting the LKB1/AMPK pathway by targeting Sirt1 in non-alcoholic fatty liver disease. Long JK; Dai W; Zheng YW; Zhao SP Mol Med; 2019 Jun; 25(1):26. PubMed ID: 31195981 [TBL] [Abstract][Full Text] [Related]
3. miR-34a regulates lipid metabolism by targeting SIRT1 in non-alcoholic fatty liver disease with iron overload. Wang L; Sun M; Cao Y; Ma L; Shen Y; Velikanova AA; Li X; Sun C; Zhao Y Arch Biochem Biophys; 2020 Nov; 695():108642. PubMed ID: 33098868 [TBL] [Abstract][Full Text] [Related]
4. microRNA-141 is associated with hepatic steatosis by downregulating the sirtuin1/AMP-activated protein kinase pathway in hepatocytes. Yousefi Z; Nourbakhsh M; Abdolvahabi Z; Ghorbanhosseini SS; Hesari Z; Yarahmadi S; Ezzati-Mobasser S; Seiri P; Borji M; Meshkani R; Malek M J Cell Physiol; 2020 Feb; 235(2):880-890. PubMed ID: 31256424 [TBL] [Abstract][Full Text] [Related]
5. MicroRNA-141 Targets Sirt1 and Inhibits Autophagy to Reduce HBV Replication. Yang Y; Liu Y; Xue J; Yang Z; Shi Y; Shi Y; Lou G; Wu S; Qi J; Liu W; Wang J; Chen Z Cell Physiol Biochem; 2017; 41(1):310-322. PubMed ID: 28135713 [TBL] [Abstract][Full Text] [Related]
6. miR-23b-3p induces the cellular metabolic memory of high glucose in diabetic retinopathy through a SIRT1-dependent signalling pathway. Zhao S; Li T; Li J; Lu Q; Han C; Wang N; Qiu Q; Cao H; Xu X; Chen H; Zheng Z Diabetologia; 2016 Mar; 59(3):644-54. PubMed ID: 26687158 [TBL] [Abstract][Full Text] [Related]
8. Beraprost sodium, a prostacyclin analogue, reduces fructose-induced hepatocellular steatosis in mice and in vitro via the microRNA-200a and SIRT1 signaling pathway. Zhang P; Xu L; Guan H; Liu L; Liu J; Huang Z; Cao X; Liao Z; Xiao H; Li Y Metabolism; 2017 Aug; 73():9-21. PubMed ID: 28732575 [TBL] [Abstract][Full Text] [Related]
9. Altered microRNA-9 Expression Level is Directly Correlated with Pathogenesis of Nonalcoholic Fatty Liver Disease by Targeting Onecut2 and SIRT1. Ao R; Wang Y; Tong J; Wang BF Med Sci Monit; 2016 Oct; 22():3804-3819. PubMed ID: 27756894 [TBL] [Abstract][Full Text] [Related]
10. Activation of the SIRT1/p66shc antiapoptosis pathway via carnosic acid-induced inhibition of miR-34a protects rats against nonalcoholic fatty liver disease. Shan W; Gao L; Zeng W; Hu Y; Wang G; Li M; Zhou J; Ma X; Tian X; Yao J Cell Death Dis; 2015 Jul; 6(7):e1833. PubMed ID: 26203862 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of sirtuin 1 deacetylase by miR-211-5p provides a mechanism for the induction of cell death in breast cancer cells. Yarahmadi S; Abdolvahabi Z; Hesari Z; Tavakoli-Yaraki M; Yousefi Z; Seiri P; Hosseinkhani S; Nourbakhsh M Gene; 2019 Aug; 711():143939. PubMed ID: 31220581 [TBL] [Abstract][Full Text] [Related]
12. Upregulation of miR-181a impairs lipid metabolism by targeting PPARα expression in nonalcoholic fatty liver disease. Huang R; Duan X; Liu X; Cao H; Wang Y; Fan J; Wang B Biochem Biophys Res Commun; 2019 Jan; 508(4):1252-1258. PubMed ID: 30558790 [TBL] [Abstract][Full Text] [Related]
13. miR-107 orchestrates ER stress induction and lipid accumulation by post-transcriptional regulation of fatty acid synthase in hepatocytes. Bhatia H; Verma G; Datta M Biochim Biophys Acta; 2014; 1839(4):334-43. PubMed ID: 24560669 [TBL] [Abstract][Full Text] [Related]
14. miR-26a Potentially Contributes to the Regulation of Fatty Acid and Sterol Metabolism In Vitro Human HepG2 Cell Model of Nonalcoholic Fatty Liver Disease. Ali O; Darwish HA; Eldeib KM; Abdel Azim SA Oxid Med Cell Longev; 2018; 2018():8515343. PubMed ID: 30402207 [TBL] [Abstract][Full Text] [Related]
15. MicroRNA-185 regulates expression of lipid metabolism genes and improves insulin sensitivity in mice with non-alcoholic fatty liver disease. Wang XC; Zhan XR; Li XY; Yu JJ; Liu XM World J Gastroenterol; 2014 Dec; 20(47):17914-23. PubMed ID: 25548489 [TBL] [Abstract][Full Text] [Related]
16. Downregulation of miR-181a upregulates sirtuin-1 (SIRT1) and improves hepatic insulin sensitivity. Zhou B; Li C; Qi W; Zhang Y; Zhang F; Wu JX; Hu YN; Wu DM; Liu Y; Yan TT; Jing Q; Liu MF; Zhai QW Diabetologia; 2012 Jul; 55(7):2032-43. PubMed ID: 22476949 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of microRNA-9-3p reduces lipid accumulation in HepG2 cells by targeting the expression of sirtuin type 1. Sun YN; Li S; Zhou YT; Liu J; Tian LB; Zhen YF; Fang H Mol Med Rep; 2015 Nov; 12(5):7742-8. PubMed ID: 26459099 [TBL] [Abstract][Full Text] [Related]
18. miR-21 regulates triglyceride and cholesterol metabolism in non-alcoholic fatty liver disease by targeting HMGCR. Sun C; Huang F; Liu X; Xiao X; Yang M; Hu G; Liu H; Liao L Int J Mol Med; 2015 Mar; 35(3):847-53. PubMed ID: 25605429 [TBL] [Abstract][Full Text] [Related]
19. miR-23b-3p regulates apoptosis and autophagy via suppressing SIRT1 in lens epithelial cells. Zhou W; Xu J; Wang C; Shi D; Yan Q J Cell Biochem; 2019 Dec; 120(12):19635-19646. PubMed ID: 31338869 [TBL] [Abstract][Full Text] [Related]
20. MiR-181b regulates steatosis in nonalcoholic fatty liver disease via targeting SIRT1. Wang Y; Zhu K; Yu W; Wang H; Liu L; Wu Q; Li S; Guo J Biochem Biophys Res Commun; 2017 Nov; 493(1):227-232. PubMed ID: 28899784 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]